Ultrasis, a provider of interactive health care services, also features in this weekend's FT. Investors who bought shares early this year when the share price hovered just above 0.2p will be sitting on very healthy paper profits indeed.
http://www.ft.com/cms/s/0/3c83aa18-4323-11e3-9d3c-00144feabdc0.html?siteedition=uk#axzz2jV2hHMc1
It's not a company I'm familiar with, and a quick look through it's financials doesn't inspire me to buy shares in the company. From what I can see revenues and profits have steadily fallen over the past five years, and indeed the company was loss making in 2011 and 2012.
Whilst they have recently won a new, possibly lucrative contract, the financial details of the contract have not been disclosed.
Losses at the interim stage of 2013 have continued and the balance sheet doesn't look very strong.
What would also concern me is that they appear to have just acquired a £0.5m revenue company with a pre-tax profit of just £91,000 for nearly £5m. Ultrasis itself is currently valued at £18.5m.
I might be missing something here, and "Beating the Blues" might be a massive booster to revenue and earnings in the future, but with revenue of just £480,000 at the interim stage, there's an awful lot of expectation already priced in.
As ever, no advice intended or given.
Saturday, 2 November 2013
Netplay - worth a flutter?
Netplay, an interactive gaming company looks interesting. This week's FT features a small article regarding it's recent acquisition of Vernon's.
http://www.ft.com/cms/s/0/3c83aa18-4323-11e3-9d3c-00144feabdc0.html?siteedition=uk#axzz2jV2hHMc1
Netplay used to feature on my monitor, but it's not one that I followed very closely and I don't own any shares.
However, I've just cast my eyes over the company again, and it does appear to have been progressing well, and certainly has potential.
The shares have fallen below 5p in the not too distant past (2011) and in fact traded just below 12p as recently as early this year, I suspect that they may have much further to run though with a medium/long term view.
Broker forecasts are for 1.53p in the year ending Dec 2013 and 1.83p in 2014 giving forward EPS of 14 and 12 respectively. However, I would expect these to be upgraded given that the Vernons acquisition is immediately earnings enhancing. A recent trading statement (pre Vernons) confirmed that trading continued to be strong and that they were confident of meeting market expectations.
What I like about this company is that it is strongly cash generative and appears to be growing at a very healthy rate, and as far as I can see it doesn't have any debt. In fact it currently boasts £15m in cash on it's balance sheet which is nearly a quarter of its current market cap.
The strong cash generation will enable the company to continue with a progressive dividend policy whilst at the same time pick up strategic acquisitions to help further it's growth.
It appears to a be a company that doesn't immediately look cheap, but on closer inspection and with continued growth momentum, it may well prove to be a very profitable medium to long term prospect.
As ever, no advice intended or given.
http://www.ft.com/cms/s/0/3c83aa18-4323-11e3-9d3c-00144feabdc0.html?siteedition=uk#axzz2jV2hHMc1
Netplay used to feature on my monitor, but it's not one that I followed very closely and I don't own any shares.
However, I've just cast my eyes over the company again, and it does appear to have been progressing well, and certainly has potential.
The shares have fallen below 5p in the not too distant past (2011) and in fact traded just below 12p as recently as early this year, I suspect that they may have much further to run though with a medium/long term view.
Broker forecasts are for 1.53p in the year ending Dec 2013 and 1.83p in 2014 giving forward EPS of 14 and 12 respectively. However, I would expect these to be upgraded given that the Vernons acquisition is immediately earnings enhancing. A recent trading statement (pre Vernons) confirmed that trading continued to be strong and that they were confident of meeting market expectations.
What I like about this company is that it is strongly cash generative and appears to be growing at a very healthy rate, and as far as I can see it doesn't have any debt. In fact it currently boasts £15m in cash on it's balance sheet which is nearly a quarter of its current market cap.
The strong cash generation will enable the company to continue with a progressive dividend policy whilst at the same time pick up strategic acquisitions to help further it's growth.
It appears to a be a company that doesn't immediately look cheap, but on closer inspection and with continued growth momentum, it may well prove to be a very profitable medium to long term prospect.
As ever, no advice intended or given.
Friday, 1 November 2013
Bid rumours and Director purchases - Angle and Regenersis
Note to self. Never try and predict what might happen with company share prices from one week to the next. One of my recent blogs entitled "Angle - next week's biggest riser?" has turned out to be a bit of a damp squib.
http://michae1mouse.blogspot.co.uk/2013/10/angle-next-weeks-biggest-riser.html
Whilst I didn't attend yesterday's AGM, bulletin board posters that did attend have reported that the Directors have scotched rumours of any imminent MBO or bid approach. However, progress does appear to be on track with their Parsortix device which could hopefully propel the company into a multi-million pound market cap. in the medium to long term. Fingers crossed, excepting that this is a speculative investment.
I'll refrain from further comment on the Times bid speculation because ultimately I would be extremely pleased if Angle can successfully go it alone. Certainly it would be more lucrative for shareholders in the longer term.
However, before I leave the bid rumour topic alone completely, I'll just say this. In April this year, Verizon Wireless denied any interest in making a joint bid for Vodafone with AT&T, despite press rumours. In essence they were right to deny the rumours, but of course whilst the press didn't get it quite right, in less than a year Vodafone's stake in Verizon has been spun out of the company and back to Verizon and now AT&T are purportedly exploring a possible bid over the rest of Vodafone.
No smoke without fire? Who knows? Anyway, I'll move on. Needless to say I still hold all my shares in Angle.
I found this morning's post by paulypilot a very interesting read where he relates his experience of using too much gearing. A sobering read which is refreshingly honest.
http://www.stockopedia.com/content/small-cap-value-report-1-nov-puri-esch-78727/
As I've mentioned I never use spread bets, but if I had ever entertained the thought then Paul's article would certainly put me off.
He also makes a good point about Director's buying and selling shares in their own companies. I wrote a blog describing my thoughts on this topic in 2011:-
http://michae1mouse.blogspot.co.uk/2011/03/put-your-money-where-your-mouth-is.html
A company where Director's have consistently been purchasing shares in recent months is Regenersis. I have looked at the company several times , but haven't bought the shares. Firstly I prefer to buy very small and micro-cap companies (although not always), but secondly I favour a balance sheet backed by tangible assets. Whilst Regenersis has £39m in net assets, there is £40m of goodwill on the balance sheet.
However, the Directors are clearly bullish and they appear to have good reason to be. From their recent report to end of June 2013, operating profit more than doubled to GBP7.1 million (2012: GBP2.1 million), and operating cash flow more than doubled to GBP9.9 million (2012: GBP4.9 million). Adjusted EPS increased by 21% to 16.80p (2012: 13.85p) and basic EPS increased by 216% to 10.53p (2012: 3.33p).
The short, medium and long term outlook statement is very bullish,
"In June 2011, we set out a strategy to target double digit rates of growth in revenue and profits for the following 2-3 years. We have achieved that. Having invested well, we now believe the opportunity exists to continue to grow annually at double digit rates of growth for the foreseeable future."
Last year the dividend was increased 127% to 2.5p (1.1p in 2012).
The historic p/e ratio (2013) is around 25 and the dividend yield about 1%.
Broker forecasts for 2014 come in at 18.37p (although this is adjusted EPS) giving a forward P/E of 14.
Overall, it's probably fairly valued at this price in my opinion, but it may be of interest for some should the share price take a dip.
As ever, no advice intended or given.
http://michae1mouse.blogspot.co.uk/2013/10/angle-next-weeks-biggest-riser.html
Whilst I didn't attend yesterday's AGM, bulletin board posters that did attend have reported that the Directors have scotched rumours of any imminent MBO or bid approach. However, progress does appear to be on track with their Parsortix device which could hopefully propel the company into a multi-million pound market cap. in the medium to long term. Fingers crossed, excepting that this is a speculative investment.
I'll refrain from further comment on the Times bid speculation because ultimately I would be extremely pleased if Angle can successfully go it alone. Certainly it would be more lucrative for shareholders in the longer term.
However, before I leave the bid rumour topic alone completely, I'll just say this. In April this year, Verizon Wireless denied any interest in making a joint bid for Vodafone with AT&T, despite press rumours. In essence they were right to deny the rumours, but of course whilst the press didn't get it quite right, in less than a year Vodafone's stake in Verizon has been spun out of the company and back to Verizon and now AT&T are purportedly exploring a possible bid over the rest of Vodafone.
No smoke without fire? Who knows? Anyway, I'll move on. Needless to say I still hold all my shares in Angle.
I found this morning's post by paulypilot a very interesting read where he relates his experience of using too much gearing. A sobering read which is refreshingly honest.
http://www.stockopedia.com/content/small-cap-value-report-1-nov-puri-esch-78727/
As I've mentioned I never use spread bets, but if I had ever entertained the thought then Paul's article would certainly put me off.
He also makes a good point about Director's buying and selling shares in their own companies. I wrote a blog describing my thoughts on this topic in 2011:-
http://michae1mouse.blogspot.co.uk/2011/03/put-your-money-where-your-mouth-is.html
A company where Director's have consistently been purchasing shares in recent months is Regenersis. I have looked at the company several times , but haven't bought the shares. Firstly I prefer to buy very small and micro-cap companies (although not always), but secondly I favour a balance sheet backed by tangible assets. Whilst Regenersis has £39m in net assets, there is £40m of goodwill on the balance sheet.
However, the Directors are clearly bullish and they appear to have good reason to be. From their recent report to end of June 2013, operating profit more than doubled to GBP7.1 million (2012: GBP2.1 million), and operating cash flow more than doubled to GBP9.9 million (2012: GBP4.9 million). Adjusted EPS increased by 21% to 16.80p (2012: 13.85p) and basic EPS increased by 216% to 10.53p (2012: 3.33p).
The short, medium and long term outlook statement is very bullish,
"In June 2011, we set out a strategy to target double digit rates of growth in revenue and profits for the following 2-3 years. We have achieved that. Having invested well, we now believe the opportunity exists to continue to grow annually at double digit rates of growth for the foreseeable future."
Last year the dividend was increased 127% to 2.5p (1.1p in 2012).
The historic p/e ratio (2013) is around 25 and the dividend yield about 1%.
Broker forecasts for 2014 come in at 18.37p (although this is adjusted EPS) giving a forward P/E of 14.
Overall, it's probably fairly valued at this price in my opinion, but it may be of interest for some should the share price take a dip.
As ever, no advice intended or given.
Subscribe to:
Posts (Atom)